CA2085120A1 - Heterocyclic anthracyclinone and anthracycline analogs - Google Patents

Heterocyclic anthracyclinone and anthracycline analogs

Info

Publication number
CA2085120A1
CA2085120A1 CA002085120A CA2085120A CA2085120A1 CA 2085120 A1 CA2085120 A1 CA 2085120A1 CA 002085120 A CA002085120 A CA 002085120A CA 2085120 A CA2085120 A CA 2085120A CA 2085120 A1 CA2085120 A1 CA 2085120A1
Authority
CA
Canada
Prior art keywords
compound
formula
group
dioxo
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002085120A
Other languages
English (en)
French (fr)
Inventor
Giorgio G. Attardo
Yao Chang Xu
Jean-Francois Lavallee
Rabindra N. Rej
Bernard Belleau (Deceased)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire Canada Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2085120A1 publication Critical patent/CA2085120A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Forms Removed On Construction Sites Or Auxiliary Members Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
CA002085120A 1990-06-11 1991-06-10 Heterocyclic anthracyclinone and anthracycline analogs Abandoned CA2085120A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53610790A 1990-06-11 1990-06-11
US536,107 1990-06-11

Publications (1)

Publication Number Publication Date
CA2085120A1 true CA2085120A1 (en) 1991-12-12

Family

ID=24137175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002085120A Abandoned CA2085120A1 (en) 1990-06-11 1991-06-10 Heterocyclic anthracyclinone and anthracycline analogs

Country Status (18)

Country Link
EP (1) EP0533744A1 (cs)
JP (1) JPH06504034A (cs)
CN (1) CN1058781A (cs)
AP (1) AP340A (cs)
AU (1) AU653348B2 (cs)
CA (1) CA2085120A1 (cs)
CS (1) CS178691A3 (cs)
FI (1) FI925611L (cs)
HU (1) HU9203720D0 (cs)
IE (1) IE911965A1 (cs)
IL (1) IL98460A0 (cs)
MA (1) MA22178A1 (cs)
NZ (1) NZ238490A (cs)
PL (1) PL297164A1 (cs)
PT (1) PT97931A (cs)
WO (1) WO1991019725A2 (cs)
YU (1) YU103391A (cs)
ZA (1) ZA914452B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606037A (en) * 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) * 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
AU5414094A (en) * 1992-11-09 1994-06-08 Biochem Pharma Inc. Antineoplastic heteronaphthoquinones
WO1995012588A1 (en) * 1993-11-05 1995-05-11 Biochem Pharma Inc. Antineoplastic heteronaphthoquinones
IT1271689B (it) * 1994-08-04 1997-06-04 Menarini Farma Ind 8-fluoro-antracicline, loro processi di preparazione e composizioni farmaceutiche che le contengono
BR112021003156A2 (pt) 2018-08-23 2021-05-11 Seagen, Inc. composição, anticorpo que se liga ao tigit humano, formulação farmacêutica, polinucleotídeo isolado, vetor, célula hospedeira, métodos para a produção de um anticorpo que se liga ao tigit humano e de anticorpos afucosilados que se ligam a tigit e para o tratamento de um câncer, e, kit.
CN111087377B (zh) * 2020-03-19 2020-06-26 广东省微生物研究所（广东省微生物分析检测中心） 苯并异色满醌类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52148088A (en) * 1976-06-01 1977-12-08 Richardson Merrell Inc 111aminoalkylmorphansridinee 111ols
JPS6030315B2 (ja) * 1976-06-01 1985-07-16 三井東圧化学株式会社 ４−ハロゲノメチルイソクマリン誘導体の製造法
GB2067552B (en) * 1980-01-16 1984-02-29 Erba Farmitalia Anthracyline derivatives
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
WO1991019725A2 (en) 1991-12-26
PL297164A1 (cs) 1992-10-05
HU9203720D0 (en) 1993-03-29
AU653348B2 (en) 1994-09-29
YU103391A (sh) 1994-04-05
FI925611A7 (fi) 1992-12-10
NZ238490A (en) 1994-03-25
AP340A (en) 1994-05-13
PT97931A (pt) 1992-03-31
WO1991019725A3 (en) 1992-04-30
AP9100278A0 (en) 1991-07-31
ZA914452B (en) 1992-06-24
AU8097391A (en) 1992-01-07
IL98460A0 (en) 1992-07-15
EP0533744A1 (en) 1993-03-31
IE911965A1 (en) 1991-12-18
FI925611A0 (fi) 1992-12-10
FI925611L (fi) 1992-12-10
MA22178A1 (fr) 1991-12-31
CS178691A3 (en) 1992-01-15
CN1058781A (zh) 1992-02-19
JPH06504034A (ja) 1994-05-12

Similar Documents

Publication Publication Date Title
DE69615016T2 (de) Pentacyclische verbindungen
Křen et al. Glycosylation of silybin
CA2286796C (en) Nucleophile substituted ecteinascidins and n-oxide ecteinascidins
HU211824A9 (en) Baccatine iii derivatives
US5593970A (en) Heterocyclic anthracycline analogs
Rehman et al. Incensfuran: isolation, X-ray crystal structure and absolute configuration by means of chiroptical studies in solution and solid state
Liu et al. A Fries-type rearrangement strategy for the construction of stereodefined quaternary pseudoanomeric centers: an entry into C-naphthyl ketosides
US4697005A (en) 1-fluoro, 4-fluoro, and 1,4-difluoro anthracycline anticancer antibiotics
TW462966B (en) Novel triptolide derivatives useful in the treatment of autoimmune diseases
Bruno et al. Sesquiterpene lactones and other constituents of Centaurea napifolia
BE1000407A4 (fr) Anthracycline glycosides a activite antitumorale, leur preparation, les composes intermediaires de cette preparation, et compositions et utilisation de ces substances.
AU653348B2 (en) Heterocyclic anthracyclinone and anthracycline analogs
Estévez-Braun et al. Structural elucidation and conformational analysis of new lignan butenolides from the leaves of bupleurum salicifolium.
Kovačević et al. Asymmetric synthesis and biological evaluation of (+)-cardiobutanolide,(−)-3-deoxycardiobutanolide and analogues as antiproliferative agents
Willuhn et al. Structure Revision of Xanthalongin and Further Sesquiterpene Lactones from Flowers of Arnica longifolia1
CA2146548A1 (en) Antineoplastic heteronaphthoquinones
Svirčev et al. Conformationally restricted goniofufurone mimics with halogen, azido or benzoyloxy groups at the C-7 position: Design, synthesis and antiproliferative activity
WO2006081659A1 (en) Meroterpenoid inhibitors of phosphoinositide 3 kinase (pi3k)
US5736523A (en) Antineoplastic heteronapthoquinones
US5514708A (en) Cytotoxic metabolites from Myriapora truncata
JP7405855B2 (ja) 生理活性化合物
US4663445A (en) 1-fluoro, 4-fluoro, and 1,4-difluoro-2'-halo anthracycline antibiotics
Sharma et al. Radical reactions on enol-esters: facile synthesis of 3-ulosonic acid derivatives and chiral spiroacetals
Cowin et al. Selective reduction of serrulatenol as a route to seco-pseudopterosin analogues
JP3524164B2 (ja) 抗腫瘍性物質アレナスタチンａおよび該化合物を活性成分として含有する抗腫瘍剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued